Cargando…

Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus

BACKGROUND: Fulminant type 1 diabetes mellitus (FT1DM) onsets abruptly and usually occurs within 1 week after the onset of hyperglycemic symptoms. Glycated albumin (GA) and 1,5-anhydroglucitol (1,5-AG) are indicators that reflect short-term glucose levels. This study was aimed at investigating wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ying, Lingwen, Ma, Xiaojing, Shen, Yun, Lu, Jingyi, Lu, Wei, Zhu, Wei, Wang, Yufei, Bao, Yuqian, Zhou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115050/ https://www.ncbi.nlm.nih.gov/pubmed/32280712 http://dx.doi.org/10.1155/2020/1243630

Ejemplares similares

Classic Type 1 Diabetes Mellitus and Fulminant Type 1 Diabetes Mellitus: Similarity and Discrepancy of Immunological Characteristics and Cytokine Profile
por: Ying, Lingwen, et al.
Publicado: (2021)

Comparative Agreement Analysis of Differences in 1,5-Anhydroglucitol, Glycated Albumin, and Glycated Hemoglobin A1c Levels between Fasting and Postprandial States in Steamed Bread Meal Test
por: Su, Hang, et al.
Publicado: (2017)

Saliva 1,5-anhydroglucitol is associated with early-phase insulin secretion in Chinese patients with type 2 diabetes
por: Ying, Lingwen, et al.
Publicado: (2021)

Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1c
por: Ma, Xiaojing, et al.
Publicado: (2015)

Correlation of glycated albumin but not hemoglobin A(1c) with endogenous insulin secretion in fulminant type 1 diabetes mellitus
por: Koga, Masafumi, et al.
Publicado: (2010)

Estimation of Duration of Symptoms in Fulminant Type 1 Diabetes Mellitus Using HbA(1c) or Glycated Albumin
por: Kawabe, Akitsu, et al.
Publicado: (2012)

Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes
por: Shen, Yun, et al.
Publicado: (2020)

Fulminant type 1 diabetes mellitus in pregnancy
por: Li, Chun-Yu, et al.
Publicado: (2020)

Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
por: Lee, Ji-Eun
Publicado: (2015)

Association of Advanced Glycation End Products With Lower-Extremity Atherosclerotic Disease in Type 2 Diabetes Mellitus
por: Ying, Lingwen, et al.
Publicado: (2021)

Serum 1,5-anhydroglucitol when used with fasting plasma glucose improves the efficiency of diabetes screening in a Chinese population
por: Ying, Lingwen, et al.
Publicado: (2017)

Fulminant type 1 diabetes mellitus: Two case reports
por: You, Wei, et al.
Publicado: (2019)

Postload Glycated Albumin as an Alternate Measure for Diabetes Screening in a Chinese Population
por: Su, Hang, et al.
Publicado: (2018)

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012)
por: Imagawa, Akihisa, et al.
Publicado: (2012)

A Case of Fulminant Type 1 Diabetes in a Patient with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2017)

Serum Glycated Albumin to Guide the Diagnosis of Diabetes Mellitus
por: Wu, Wan-Chen, et al.
Publicado: (2016)

1,5-Anhydroglucitol as a marker of maternal glycaemic control and predictor of neonatal birthweight in pregnancies complicated by type 1 diabetes mellitus
por: Nowak, N., et al.
Publicado: (2013)

Acute pancreatitis may be a pathogenic factor of fulminant type 1 diabetes mellitus
por: Chen, Ya-Ning, et al.
Publicado: (2021)

Fulminant type 1 diabetes mellitus with anti‐programmed cell death‐1 therapy
por: Okamoto, Masahide, et al.
Publicado: (2016)

Glycated albumin is an optimal biomarker for gestational diabetes mellitus
por: HUANG, YAPING, et al.
Publicado: (2015)

The diagnostic value of glycated albumin in gestational diabetes mellitus
por: Zhu, Jieping, et al.
Publicado: (2017)

Development of Fulminant Type 1 Diabetes Mellitus in a Patient with DRESS Syndrome
por: Perez, Pedro, et al.
Publicado: (2020)

THU374 Fulminant Type 1 Diabetes Mellitus And DKA Secondary To Pembrolizumab
por: Iqbal, Iqra, et al.
Publicado: (2023)

Two types of fulminant type 1 diabetes mellitus: Immune checkpoint inhibitor‐related and conventional
por: Imagawa, Akihisa
Publicado: (2020)

Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
por: Lu, Jingyi, et al.
Publicado: (2018)

Decreased Serum Dickkopf-1 Levels After Hypoglycemic Therapy in Patients with Type 2 Diabetes Mellitus
por: Gao, Fei, et al.
Publicado: (2022)

Diagnostic criteria for acute‐onset type 1 diabetes mellitus (2012): Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute‐onset Type 1 Diabetes Mellitus
por: Kawasaki, Eiji, et al.
Publicado: (2014)

Circulating TGF-β1, Glycation, and Oxidation in Children with Diabetes Mellitus Type 1
por: Jakuš, Vladimír, et al.
Publicado: (2012)

Case of fulminant type 1 diabetes mellitus associated with parvovirus B19 infection
por: Nishiumi, Tomoko, et al.
Publicado: (2014)

Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma
por: Ikeda, Munehiro, et al.
Publicado: (2022)

Comprehensive overview of human serum albumin glycation in diabetes mellitus
por: Qiu, Hong-Yan, et al.
Publicado: (2021)

Immune checkpoint inhibitors-related pancreatitis with fulminant type 1 diabetes mellitus: case report and literature review
por: Fang, Wei, et al.
Publicado: (2023)

The characteristics of blood glucose fluctuations in patients with fulminant type 1 diabetes mellitus in the stable stage
por: Wang, Jie, et al.
Publicado: (2018)

Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report
por: Lin, Rong, et al.
Publicado: (2022)

1,5-anhydroglucitol is a good predictor for the treatment effect of the Sodium-Glucose cotransporter 2 inhibitor in Japanese patients with type 2 diabetes mellitus
por: Usui, Masahiro, et al.
Publicado: (2020)

Fulminant type 1 diabetes mellitus associated with Coxsackievirus type B1 infection during pregnancy: a case report
por: Hayakawa, Takahiro, et al.
Publicado: (2019)

Glycated albumin is correlated with glycated hemoglobin in type 2 diabetes
por: Ciobanu, Dana Mihaela, et al.
Publicado: (2019)

Serum fructosamine, serum glycated albumin and serum glycated β-lipoprotein in type 2 diabetes mellitus patients with and without microvascular complications
por: Kalaria, Tejaskumar R., et al.
Publicado: (2016)

Bi-weekly Glycated Albumin Measurement was Useful to Encourage Behavioral Changes in People with Type 2 Diabetes Mellitus
por: Aihara, Masakazu, et al.
Publicado: (2023)

Fulminant Type 1 Diabetes Mellitus Presenting 15 Days after Delivery Diagnosed in Cooperation with Obstetricians
por: Sagawa, Junji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bk45kimj6k66koh0d45tuphiq1